(F) Complex Mutagenic Disorders and Other Cytogenetic Phenomena Flashcards

1
Q

He is a founder of?

Identify the pointed structure
A

Eugenics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who is the founder of Eugenics?

A

Sir Francis Galton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the study of the physical and mental improvement of human race

A

Sir Francis Galton

Eugenics talaga ‘yon mali ko

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Manual-based

He studied the inheritance of traits and observed what he called “blending” characters which is now known as quantitative traits or continuous variation, referring to gradation in phenotypic expressions wherein the phenotypes do not fall into distinct categories.

A

Sir Galton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

manual-based

The quantitative traits or continuous variation, refers to what in phenotypic expressions wherein the phenotypes do not fall into distinct categories.

A

gradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Manual-based

TOF. Some traits with multifactorial inheritance do not have gradations, “nonblending traits” or traits with discontinuous variation.

A

T

e.g., human ABO blood antigen system, round or wrinkled peas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DISORDERS WITH MULTIFACTORIAL INHERITANCE

It is an interaction between (2)

A

variant forms of genes and
environmental factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DISORDERS WITH MULTIFACTORIAL INHERITANCE

TOF. It is a combination of genetic, environmental, and lifestyle factors, most of which have not yet been identified.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TOF. Complex genetic disorders develop when few polymorphisms are inherited, each of which vary minimally.

A

F

Mutagenics only develop when numerous poly are inherited, each of which vary in significance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DISORDERS WITH MULTIFACTORIAL INHERITANCE

TOF. many polymorphisms, each with a modest effect and high penetrance

A

F (low penetrance)

u like dat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A genetic variant that has at least two alleles and occurs in at least 1% of the population

A

Polymorphism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

the individual has a genetic susceptibility to develop a certain disease but does not mean that he is destined to have the disease.

A

Genetic predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Complex Multigenic Disorders/ Multifactorial Inherited Disorders

TOF. Although he has the ability to prevent or eradicate the onset of the disorder.

A

F (one cannot change his genes, he can delay or prevent the onset of the disorder.)

Alzheimer’s disease, osteoporosis, asthma, multiple sclerosis, Parkinson’s disease, and many more that occuris during aadulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Multigenic Disorder

TOF. No clear Mendelian pattern of inheritance, occur in isolation, with familial aggregation

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TOF. Environmental influence can increase or decrease the risk of the disease.

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TOF. Concordance rate between monozygotic and dizygotic twins CONTRADICT Mendelian proportion

A

T

contradicts to the mendelian pattern of inheritance kasi it has no distinct category

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

TOF. Occurs more frequently in one gender than in the other, hence, it is a sex limited trait.

A

F (but not sex-limited trait)

18
Q

Multigenic Disorders

TOF. Occur rarely in a specific ethnic group

A

F (more frequently)

19
Q

TOF. The chances of having the disease is highest when a person has no genetic factors but has exposure to the environmental factor for the disease.

A

F (highest when contains both genetic factors and exposure to the envi factor)

DUHH

20
Q

Set of autosomal recessive disorders that were originally grouped together because of the common finding of chromosome instability or fragility

A

Breakage Syndromes

21
Q

Breakage Syndromes

DNA repair gene defect -> breakage or increased recombination -> chromosome instability and widespread mutation and defect in DNA sequences -> LEADS TO??

A

cancer

22
Q

Breakage Syndromes

which does not belong:
A. Ataxia Telangiectasia
B. Cocky Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

B (Cockayne Syndrome)

23
Q

Breakage Syndromes

Cytogenetic manifestation: Increased chromosome breakage detected by treatment with mitomycin C and diepoxybutane

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

D

Group A: 16q24.3 Group C- 9q22.3 Group D- 3p22-p26 Group E- 6p21-p22 Group B, F, H unmapped

24
Q

Cytogenetic manifestation: Increased sister chromatid exchange in response to UV light or BrdU incorporation

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

C

15q26.1

25
Q

Cytogenetic manifestation: Increase in SCE and chromosome rearrangement in response to UV light

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

E

Incidence: 1:250,000
A: 9q22.3
C: 653p25
D: 19q13.2-q13.3
E: 11p11-p12
F:others

26
Q

Cytogenetic manifestation: Increased spontaneous breakage, increased rings, triradials, and translocations, particularly with 7 and 14, induced with bleomycin or ionizing radiation

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

A

11q22.3

27
Q

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

sakit mo yung pinili mo

28
Q

Cytogenetic manifestation: UV sensitivity

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

B

29
Q

Type of cancer: Increased risk of AML, and progressive bone marrow failure

Clinical features: Pancytopenia, pre-or postnatal growth retardation, hypoplastic or missing thumbs, possible arm deformation, brownish pigmentation of skin

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

D (Gene locus: various; FANCA-G gene)

30
Q

Defect: Abnormal DNA ligase 1 activity

Clinical features: Growth retardation, butterfly rash on face, possible malignancy

Type of cancer: various

Miscellaneous: High frequency in Ashkenazi Jewish population;1:110 carrier frequency

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

C (Gene locus: 15q26.1, BLM gene)

31
Q

Clinical features: Ataxia with degeneration of CNS, telangiectasia on face, deficiency in cellular immunity, degenerative, growth retardation

Type of cancer: Various leukemias and solid tumors

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

A (Gene locus: 11q22.3; ATM gene)

32
Q

DNA Repair Defect: 1) lack of excision of thymine dimers; 2) Postreplication repair defect

Clinical features: Sensitivity to sun, neurological abnormalities, ataxia and spasticity

Type of cancer: Increased incidence of skin cancer

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

E (Gene locus: Incidence: 1:250,000; XPA-G & POLH gene)

33
Q

Defect: possible DNA ligase deficiency or defect of transcription coupled repair

Clinical features: dwarfism, premature aging, microcephaly, neurologic deficit, pigmentary degeneration, deafness, sensitivity to sunlight, MR

Type of cancer: increased incidence of skin cancer

A. Ataxia Telangiectasia
B. Cockayne Syndrome
C. Bloom Syndrome
D. Fanconi Anemia
E. Xeroderma Pigmentosa

A

B (Gene locus: chromosome 5)

34
Q

Fanconi Anemia

Current therapy:

A

bone marrow transplantation

35
Q

Cytogenetics and Genome Research

what has cytogenetic technology newly uncovered?

A

microdeletions

36
Q

method of syndrome identification is currently undergoing exciting development because of cytogenetic arrays (whole genome cytogenetic arrays)

A

“genotype first”

37
Q

Cytogenetics and Genome Research

TOF. can be used for children with unexplained developmental abnormalities.

A

T

38
Q

Cytogenetics and Genome Research

Tailored approaches to preventing and treating complex disorders based on genetic personalization of drug is done through the study of?

A

pharmacogenetics (single-drug interactions) and pharmacogenomics (study of many genes and their interactions with drugs)

39
Q

Molecular Cytogenetics

This diagnositic may become the most powerful tool for the diagnosis and screening of human diseases.

TOF

A

T

40
Q

This can predict which patients will response to certain drug and not, and who will manifest adverse effects are looked for.

A

Biomarkers

41
Q

Molecular Cytogenetics

TOF. its ability to diagnose disease both prenatally and pre- symptomatically confers it a secondary role in preventive medicine.

A

F (primary)

42
Q

CONGRATS TAPOS KA NA

A

pero assess mo muna sarili mo, labyu pa rin so proud!